Literature DB >> 10579043

Clinical findings, treatment, and outcome of dogs with status epilepticus or cluster seizures: 156 cases (1990-1995).

S W Bateman1, J M Parent.   

Abstract

OBJECTIVE: To report clinical findings, treatments, and outcomes of dogs admitted to the hospital for status epilepticus or cluster seizures and evaluate factors associated with outcome.
DESIGN: Retrospective study. ANIMALS: 156 dogs admitted for status epilepticus or cluster seizures. PROCEDURE: Medical records were reviewed for seizure and medication history, diagnostic test results, types of treatment, hospitalization costs, and outcome of hospital visits.
RESULTS: Dogs were admitted for seizures on 194 occasions. Of 194 admissions, 128 (66%), 2 (1%), 32 (16.5%), 2 (1%), and 30 (15.5%) were of dogs with a history of clusters of generalized seizures, clusters of partial complex seizures, convulsive status epilepticus, partial status epilepticus, and > 1 type of seizure, respectively. Underlying causes of seizures were primary epilepsy (26.8%; 52/194), secondary epilepsy (35.1%; 68), reactive epileptic seizures (6.7%; 13), primary or secondary epilepsy with low serum antiepileptic drug concentrations (5.7%; 11), and undetermined (25.8%; 50). One hundred and eighty-six hospital visits resulted in admission to the intensive care unit (ICU). Treatments with continuous i.v. infusions of diazepam or phenobarbital were initiated during 66.8% (124/186) and 18.7% (35) of ICU hospital stays for 22.3 +/- 16.1 hours (mean +/- SD) and 21.9 +/- 15.4 hours, respectively. Of 194 admissions, 74.7% (145) resulted in discharge from the hospital, 2.1% (4) in death, and 23.2% (45) in euthanasia. A poor outcome (death or euthanasia) was significantly associated with granulomatous meningoencephalitis, loss of seizure control after 6 hours of hospitalization, and the development of partial status epilepticus. CONCLUSIONS AND CLINICAL RELEVANCE: Granulomatous meningoencephalitis, loss of seizure control after 6 hours of hospitalization, or the development of partial status epilepticus may indicate a poor prognosis for dogs with seizures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579043

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  13 in total

1.  Canine status epilepticus: a translational platform for human therapeutic trials.

Authors:  Ilo E Leppik; Edward N Patterson; Lisa D Coles; Elise M Craft; James C Cloyd
Journal:  Epilepsia       Date:  2011-10       Impact factor: 5.864

2.  Canine status epilepticus treated with fosphenytoin: A proof of principle study.

Authors:  Edward E Patterson; Ilo E Leppik; Lisa D Coles; Michael Podell; Charles H Vite; William Bush; James C Cloyd
Journal:  Epilepsia       Date:  2015-05-07       Impact factor: 5.864

3.  Clinical Risk Factors for Early Seizure Recurrence in Dogs Hospitalized for Seizure Evaluation.

Authors:  M Kwiatkowska; A Tipold; E Huenerfauth; A Pomianowski
Journal:  J Vet Intern Med       Date:  2018-02-18       Impact factor: 3.333

4.  Association between estrus and onset of seizures in dogs with idiopathic epilepsy.

Authors:  S A E Van Meervenne; H A Volk; L M L Van Ham
Journal:  J Vet Intern Med       Date:  2014-11-19       Impact factor: 3.333

5.  Intranasal Midazolam versus Rectal Diazepam for the Management of Canine Status Epilepticus: A Multicenter Randomized Parallel-Group Clinical Trial.

Authors:  M Charalambous; S F M Bhatti; L Van Ham; S Platt; N D Jeffery; A Tipold; J Siedenburg; H A Volk; D Hasegawa; A Gallucci; G Gandini; M Musteata; E Ives; A E Vanhaesebrouck
Journal:  J Vet Intern Med       Date:  2017-05-24       Impact factor: 3.333

6.  Postencephalitic epilepsy in dogs with meningoencephalitis of unknown origin: Clinical features, risk factors, and long-term outcome.

Authors:  Adriana Kaczmarska; Roberto José-López; Michał Czopowicz; Kali Lazzerini; Guillaume Leblond; Catherine Stalin; Rodrigo Gutierrez-Quintana
Journal:  J Vet Intern Med       Date:  2020-01-28       Impact factor: 3.333

7.  Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: A multi-center randomized parallel group clinical study.

Authors:  Marios Charalambous; Holger A Volk; Andrea Tipold; Johannes Erath; Enrice Huenerfauth; Antonella Gallucci; Gualtiero Gandini; Daisuke Hasegawa; Theresa Pancotto; John H Rossmeisl; Simon Platt; Luisa De Risio; Joan R Coates; Mihai Musteata; Federica Tirrito; Francesca Cozzi; Laura Porcarelli; Daniele Corlazzoli; Rodolfo Cappello; An Vanhaesebrouck; Bart J G Broeckx; Luc Van Ham; Sofie F M Bhatti
Journal:  J Vet Intern Med       Date:  2019-10-03       Impact factor: 3.333

8.  Retrospective analysis of seizures associated with feline infectious peritonitis in cats.

Authors:  Doris Timmann; Sigitas Cizinauskas; Ales Tomek; Marcus Doherr; Marc Vandevelde; André Jaggy
Journal:  J Feline Med Surg       Date:  2007-08-31       Impact factor: 2.015

9.  Analysis of Early Assessable Risk Factors for Poor Outcome in Dogs With Cluster Seizures and Status Epilepticus.

Authors:  Giulia Cagnotti; Sara Ferrini; Ugo Ala; Claudio Bellino; Cristiano Corona; Elena Dappiano; Giorgia Di Muro; Barbara Iulini; Ida Pepe; Silvia Roncone; Antonio D'Angelo
Journal:  Front Vet Sci       Date:  2020-10-09

10.  Continuous rate infusion of midazolam as emergent treatment for seizures in dogs.

Authors:  Kathryn Y Bray; Christopher L Mariani; Peter J Early; Karen R Muñana; Natasha J Olby
Journal:  J Vet Intern Med       Date:  2020-12-16       Impact factor: 3.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.